Triethylamine N-oxygenation mediated by liver and kidney microsomes and recombinant flavin-containing monooxygenase 3 (FMO3) and FMO1 proteins from humans, monkeys, pigs, and dogs
Drug Metabolism and Disposition · 2025
DOI: 10.1016/j.dmd.2025.100140 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2025. Verfasst von Makiko Shimizu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Tokyo, Japan. Hauptthemen laut MEDLINE: Oxygenases, Microsomes, Liver, Kidney, Ethylamines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
A family of NADPH-dependent flavin-containing monooxygenases (FMOs; EC 1.14.13.8) mediate the oxygenation of various N-containing molecules. Human FMO3 and FMO1 are the major hepatic and renal forms, respectively; monkey, dog, and pig FMO3 and FMO1 have also been identified. Triethylamine has been found in the urine of manufacturing workers. Although triethylamine was predicted to be metabolized by N-oxygenation by human FMO3 because of its classic base dissociation constant, enzymatic role of FMOs in triethylamine N-oxygenation remains to be investigated. Consequently, triethylamine N-oxygenation was investigated with FMO1/3 enzyme sources. The rate of triethylamine N-oxygenation mediated by human liver microsomes was similar to that mediated by human kidney microsomes. In contrast, the rates of triethylamine N-oxygenation by monkey, dog, and minipig liver microsomes were higher than those by kidney microsomes. Human liver microsomal triethylamine N-oxygenation was extensively suppressed by preheating liver microsomes at 45 °C for 5 minutes, suggesting a major role of FMOs in triethylamine N-oxygenation. Recombinant human, monkey, and dog FMO3 efficiently mediated triethylamine N-oxygenation, whereas only pig FMO1 exhibited this activity. Human liver microsomes and recombinant FMO3 showed similar Km values for triethylamine N-oxygenation. For the 4 species tested, positive correlations were observed between the rates of FMO3-mediated triethylamine N-oxygenation and its activities toward additional probe substrates benzydamine and trimethylamine. These results suggest that human FMO3 is responsible for triethylamine N-oxygenation, with some species differences in terms of FMO-mediated triethylamine N-oxygenation in humans and animal models, eg, monkeys, dogs, and minipigs. SIGNIFICANCE STATEMENT: Human flavin-containing monooxygenase (FMO) 3 mediates the N-oxygenation of triethylamine, a basic compound of interest in human biomonitoring survey results for manufacturing workers. The substrate specificity of FMO3 for triethylamine N-oxygenation in humans, monkeys, and dogs was evident. In contrast, pig FMO1 was the predominant FMO form for the N-oxygenation of triethylamine. Human hepatic FMO3 is responsible for triethylamine N-oxygenation; however, the rate of triethylamine N-oxygenation may be slower than that of typical FMO3 probe substrate trimethylamine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Tokyo, Japan.
- Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan.
- Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Tokyo, Japan. Electronic address: hiroshi-yamazaki@umin.ac.jp.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Shimizu, M., Nii, A., Uno, Y., & Yamazaki, H. (2025). Triethylamine N-oxygenation mediated by liver and kidney microsomes and recombinant flavin-containing monooxygenase 3 (FMO3) and FMO1 proteins from humans, monkeys, pigs, and dogs. Drug Metabolism and Disposition. https://doi.org/10.1016/j.dmd.2025.100140
Vancouver
Shimizu M, Nii A, Uno Y, Yamazaki H. Triethylamine N-oxygenation mediated by liver and kidney microsomes and recombinant flavin-containing monooxygenase 3 (FMO3) and FMO1 proteins from humans, monkeys, pigs, and dogs. Drug Metabolism and Disposition. 2025. doi:10.1016/j.dmd.2025.100140
BibTeX
@article{Shimizu2025,
author = {Shimizu, Makiko and Nii, Anna and Uno, Yasuhiro and Yamazaki, Hiroshi},
title = {Triethylamine N-oxygenation mediated by liver and kidney microsomes and recombinant flavin-containing monooxygenase 3 (FMO3) and FMO1 proteins from humans, monkeys, pigs, and dogs},
journal = {Drug Metabolism and Disposition},
year = {2025},
doi = {10.1016/j.dmd.2025.100140}
}
EUVIMED